KIDS icon

OrthoPediatrics

19.65 USD
-0.68
3.34%
At close Updated Sep 12, 4:00 PM EDT
Pre-market
After hours
19.65
0.00
0%
1 day
-3.34%
5 days
-6.38%
1 month
0.2%
3 months
-9.53%
6 months
-23.06%
Year to date
-14.08%
1 year
-37.82%
5 years
-56.19%
10 years
2.24%
 

About: OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.

Employees: 562

0
Funds holding %
of 7,462 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

2% more funds holding

Funds holding: 115 [Q1] → 117 (+2) [Q2]

0.53% more ownership

Funds ownership: 68.72% [Q1] → 69.25% (+0.53%) [Q2]

12% less capital invested

Capital invested by funds: $411M [Q1] → $361M (-$49.9M) [Q2]

21% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 42

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $245K

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$35
78% upside
Avg. target
$37
88% upside
High target
$39
98% upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
JMP Securities
David Turkaly
$35
Market Outperform
Maintained
8 Aug 2025
BTIG
Ryan Zimmerman
$39
Buy
Maintained
6 Aug 2025

Financial journalist opinion

Based on 3 articles about KIDS published over the past 30 days

Neutral
GlobeNewsWire
4 days ago
OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System
WARSAW, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the first U.S. surgical procedures with the VerteGlide Spinal Growth Guidance System (“VerteGlide”), used to treat Early Onset Scoliosis (“EOS”).
OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System
Neutral
GlobeNewsWire
9 days ago
OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.
WARSAW, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics announced today a new distribution partnership with MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries.
OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.
Neutral
GlobeNewsWire
20 days ago
OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors
WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025.
OrthoPediatrics Corp. Announces the Appointment of Kelly Fischer to its Board of Directors
Neutral
Seeking Alpha
1 month ago
OrthoPediatrics Corp. (KIDS) Q2 2025 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants David R. Bailey - President, CEO & Director Fred L.
OrthoPediatrics Corp. (KIDS) Q2 2025 Earnings Call Transcript
Neutral
The Motley Fool
1 month ago
OrthoPediatrics (KIDS) Q2 Revenue Up 16%
OrthoPediatrics (KIDS) Q2 Revenue Up 16%
OrthoPediatrics (KIDS) Q2 Revenue Up 16%
Neutral
Zacks Investment Research
1 month ago
OrthoPediatrics (KIDS) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
OrthoPediatrics (KIDS) Reports Q2 Earnings: What Key Metrics Have to Say
Negative
Zacks Investment Research
1 month ago
OrthoPediatrics (KIDS) Reports Q2 Loss, Misses Revenue Estimates
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.23 per share a year ago.
OrthoPediatrics (KIDS) Reports Q2 Loss, Misses Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2025.
OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics
WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) division with multiple new clinics and entry into two new territories.
OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference
WARSAW, Ind., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 45th Canaccord Genuity Annual Growth Conference, held in Boston, MA.
OrthoPediatrics Corp. to Participate in the 45th Canaccord Genuity Annual Growth Conference
Charts implemented using Lightweight Charts™